title: Mycobacterium phlei, a previously unreported cause of pacemaker infection: thinking outside the box in cardiac device infections.
abstract: The increased use of cardiac rhythm management devices has led to an increase in cardiac device-related infections (CDI). Staphylococcus aureus and epidermidis account for the vast majority of CDI. CDI due to rapidly growing non-tuberculous mycobacteria is very rare, with only about ten cases having been reported. We report a case of pacemaker pocket infection with Mycobacterium phlei. There are only three published reports of human infection involving this typically non-pathogenic organism. To the best of our knowledge, this is the first report of CDI with Mycobacterium phlei.
authors: Department of Internal Medicine, Creighton University Medical Center, Omaha, NE 68131, USA.
authors: Showri
authors: S
authors: Karnam
authors: Venkata M
authors: VM
authors: Alla
authors: Joong
authors: J
authors: Kwon
authors: Tracey
authors: T
authors: Harbert
authors: Akhilesh
authors: A
authors: Sharma
authors: Kelly
authors: K
authors: Airey
authors: Aryan
authors: A
authors: Mooss
mesh_terms: D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D058406:Cardiac Resynchronization Therapy / Q000009:adverse effects*; D058409:Cardiac Resynchronization Therapy Devices / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000628:therapy*; D003646:Debridement; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D020878:Device Removal; D005260:Female; D006801:Humans; D009164:Mycobacterium Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D009168:Mycobacterium phlei / Q000302:isolation & purification*; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents